KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced new sebetralstat findings related to time to end of progression of hereditary angioedema (HAE) attacks, and the effectiveness of ...

Details of the presentations are outlined below: Long-Term Safety and Efficacy of Oral Deucrictibant for Prophylaxis in Hereditary Angioedema: Data Snapshot Results of the CHAPTER-1 Open-Label ...

Department of Dermatology, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, China Background: Hereditary angioedema (HAE) is a life-threatening condition ...

BioCryst Pharmaceuticals, Inc. announced promising new data regarding their oral prophylactic treatment, ORLADEYO (berotralstat), for hereditary angioedema (HAE) during the 14th C1-Inhibitor ...

Angioedema (AE) syndromes are associated with recurrent, unpredictable attacks of subcutaneous and submucosal tissue swelling, which can become life-threatening. Recent classification efforts define a ...

Here, we develop a toolkit for capturing EEA1-positive endosomes (termed Endo-IP) and TMEM192-positive lysosomes (termed Lyso-IP) in stem cell-derived induced neurons (iNeurons). We demonstrate its ...

“It turns out I had something called a drug-induced liver injury, which came from my supplements.” The liver is responsible for more than 500 functions in the human body, including filtering ...

The bank shares three reasons a tariff-induced inflation spike won't be permanent. As companies such as Walmart and Target consider raising prices due to President Donald Trump's tariffs ...

Dr. Marc A. Riedl, Professor of Medicine and Clinical Director of the U.S. HAEA Angioedema Center at the University of California, San Diego, will present safety and efficacy data from the Phase 1a ...

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application for berotralstat as prophylactic therapy for pediatric patients aged 2 to 11 years with hereditary ...

Pharvaris, a biopharmaceutical company based in Zug, Switzerland, announced the acceptance of multiple abstracts for presentation at three significant upcoming congresses focusing on angioedema ...